期刊文献+

肝肾综合征临床诊断标准的变迁及新的肾损伤指标在肝硬化患者中的应用 被引量:7

Changes in diagnostic criteria for hepatorenal syndrome and the application of new renal injury indices in cirrhotic patients
下载PDF
导出
摘要 肝肾综合征是一种严重的失代偿期肝硬化并发症,短期病死率极高。目前尚缺乏有效的内科治疗方法,一些药物尽管有效,但其报道的疗效不一,原因之一是诊断标准并不统一。介绍了肝肾综合征诊断标准的变迁和新的肾损伤指标或方法,指出一个统一的诊断标准将成为肝肾综合征临床研究的基础,也有利于临床医生进一步认识此严重的肝硬化并发症。 Hepatorenal syndrome is a serious complication of decompensated cirrhosis and has high short-term mortality. There still lacks effective medical treatment at present. Although some drugs are effective,but their effects reported in the literature were different due to a lack of uniform diagnostic criteria. This article introduces the changes in the diagnostic criteria for hepatorenal syndrome and points out that uniform diagnostic criteria will become the basis for clinical research on hepatorenal syndrome and may also help clinicians to understand this serious complication of liver cirrhosis.
作者 刘沁雨 李海 LIU Qinyu;LI Hai(Department of Hepatopancreatobiliary and Splenic Medicine,Affiliated Hospital of Logistics University of Chinese People's Armed Police Forces,Tianjin 300162,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2018年第6期1308-1312,共5页 Journal of Clinical Hepatology
关键词 肝肾综合征 诊断 综述 hepatorenal syndrome diagnosis review
  • 相关文献

参考文献10

二级参考文献89

  • 1Zhu, Xiao-Feng,He, Xiao-Shun,Chen, Gui-Hua,Chen, Li-Zhong,Wang, Chang-Xi,Huang, Jie-Fu.Combined liver and kidney transplantation in Guangzhou,China[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):585-589. 被引量:5
  • 2王国华,朱瑞龙.肝硬化难治性腹水和肝肾综合征的定义和诊断标准[J].国外医学(消化系疾病分册),1996,16(4):197-199. 被引量:8
  • 3魏建威,郑登滋,陈友.血清胱抑素C测定的临床应用[J].实用医技杂志,2007,14(30):4244-4245. 被引量:26
  • 4J. A. Leithead,P. C. Hayes,J. W. Ferguson.Review article: advances in the management of patients with cirrhosis and portal hypertension‐related renal dysfunction[J]. Aliment Pharmacol Ther . 2014 (7)
  • 5Mónica Guevara,Carlos Terra,André Nazar,Elsa Solà,Javier Fernández,Marco Pavesi,Vicente Arroyo,Pere Ginès.Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study[J]. Journal of Hepatology . 2012 (4)
  • 6Virendra Singh,Souvik Ghosh,Baljinder Singh,Pradeep Kumar,Navneet Sharma,Ashish Bhalla,A.K. Sharma,N.S. Choudhary,Yogesh Chawla,C.K. Nain.Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study[J]. Journal of Hepatology . 2012 (6)
  • 7Juan Carlos Q. Velez,Paul J. Nietert.Therapeutic Response to Vasoconstrictors in Hepatorenal Syndrome Parallels Increase in Mean Arterial Pressure: A Pooled Analysis of Clinical Trials[J]. American Journal of Kidney Diseases . 2011 (6)
  • 8Thomas D. Boyer,Arun J. Sanyal,Guadalupe Garcia-Tsao,Andres Blei,Daniel Carl,Alice S. Bexon,Peter Teuber.Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics[J]. Journal of Hepatology . 2010 (2)
  • 9Ya-Wen Yang,Che-Hsiung Wu,Rey-Heng Hu,Ming-Chin Ho,Meng-Kun Tsai,Yao-Ming Wu,Po-Huang Lee.Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center[J]. Hepatology International . 2010 (2)
  • 10Sashidhar VSagi,SahilMittal,Krishna SKasturi,Gagan KSood.Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta‐analysis of randomized controlled trials[J]. Journal of Gastroenterology and Hepatology . 2010 (5)

共引文献75

同被引文献61

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部